▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁t 9.453125
O 8.2734375
her 8.625
apy 9.8671875
▁by 4.6171875
▁comparing 4.546875
▁the 0.9189453125
▁effects 2.3359375
▁of 0.038665771484375
▁p 6.390625
ahr 10.3515625
ma 1.9560546875
ce 0.01544952392578125
ut 0.0033397674560546875
ical 0.0186614990234375
▁op 0.402099609375
io 0.158447265625
ids 0.09197998046875
▁and 0.30078125
▁MM 1.6318359375
. 1.0390625
<0x0A> 1.0634765625
The 1.4365234375
▁study 2.244140625
▁was 2.296875
▁conducted 0.75732421875
▁in 1.5859375
▁the 1.455078125
▁form 2.265625
▁of 0.01468658447265625
▁collection 10.0625
▁and 1.70703125
▁analysis 0.69580078125
▁of 0.03814697265625
▁statistical 4.27734375
▁data 0.126953125
. 0.974609375
▁Part 5.0078125
icip 0.0823974609375
ants 0.054443359375
▁were 0.7451171875
▁rec 3.32421875
ru 0.002162933349609375
ited 0.00045418739318847656
▁for 4.0703125
▁six 7.69140625
▁months 0.544921875
▁at 3.81640625
▁two 2.474609375
▁major 5.4921875
▁pain 3.197265625
▁relief 5.28515625
▁cent 1.55078125
ers 0.11358642578125
▁in 0.73681640625
▁Israel 4.40234375
. 0.419921875
▁The 1.2197265625
▁research 2.185546875
ers 1.5166015625
▁used 2.63671875
▁The 7.56640625
▁De 4.3359375
pression 0.0175323486328125
▁Module 9.796875
▁of 0.9365234375
▁the 0.348388671875
▁Pat 2.3125
ient 0.009124755859375
▁Health 0.0870361328125
▁Question 0.0204620361328125
naire 0.027008056640625
▁and 3.34375
▁the 0.7529296875
▁General 1.7451171875
ized 0.72314453125
▁An 0.02197265625
x 0.00046515464782714844
iety 0.0039825439453125
▁Dis 0.63134765625
order 0.038970947265625
▁Sc 1.26171875
ale 0.0828857421875
▁to 1.7685546875
▁interview 7.0390625
▁participants 1.9619140625
, 3.74609375
▁evaluate 5.6484375
▁their 0.73779296875
▁answers 6.56640625
, 0.890625
▁and 0.153564453125
▁conduct 4.4140625
▁the 2.310546875
▁study 2.310546875
. 0.2239990234375
▁To 5.16015625
▁specifically 9.96875
▁evaluate 2.607421875
▁and 4.34765625
▁compare 0.8974609375
▁the 0.328125
▁prob 11.0234375
abilities 0.23974609375
▁of 0.1290283203125
▁de 0.876953125
pression 0.037872314453125
▁or 4.5859375
▁anx 0.042266845703125
iety 0.0009937286376953125
▁among 1.68359375
▁the 2.26953125
▁diverse 8.859375
▁groups 1.583984375
, 1.48828125
▁the 1.0107421875
▁study 2.701171875
▁used 1.63671875
▁multiple 4.640625
▁log 2.857421875
istic 0.0406494140625
▁regression 0.10064697265625
▁analysis 0.66845703125
▁and 2.501953125
▁chose 8.9765625
▁medical 7.43359375
▁mar 0.35693359375
iju 0.00884246826171875
ana 0.0018024444580078125
▁as 0.78466796875
▁the 1.0927734375
▁control 2.712890625
▁group 0.572265625
. 0.283203125
<0x0A> 0.81787109375
This 3.482421875
▁type 6.1015625
▁of 0.0092926025390625
▁study 1.791015625
▁is 1.2744140625
▁the 3.330078125
▁most 1.8916015625
▁reve 9.0625
aling 0.0013446807861328125
▁and 1.0546875
▁inclus 6.53125
ive 0.0032863616943359375
, 2.34375
▁as 1.8779296875
▁it 0.345458984375
▁contains 4.97265625
▁direct 6.39453125
▁responses 4.97265625
▁from 0.81396484375
▁a 3.923828125
▁large 0.966796875
▁number 0.43701171875
▁of 0.004016876220703125
▁participants 1.41796875
. 0.63818359375
▁All 4.64453125
▁tools 9.15625
▁in 4.51171875
▁the 0.6806640625
▁form 3.46484375
▁of 0.04351806640625
▁question 1.71875
na 0.03753662109375
ires 0.00021266937255859375
▁and 2.087890625
▁scales 3.185546875
▁have 3.6875
▁already 4.4921875
▁been 0.1781005859375
▁used 1.9169921875
▁and 2.10546875
▁proved 4.16015625
▁their 1.7333984375
▁effic 3.826171875
acy 0.0002148151397705078
▁for 3.623046875
▁collect 4.671875
ing 0.01708984375
▁analyt 8.234375
ical 0.2431640625
▁data 0.27587890625
. 0.42626953125
▁It 3.537109375
▁helps 4.7890625
▁to 0.96484375
▁system 7.34375
at 1.2587890625
ize 0.01280975341796875
▁and 1.5888671875
▁class 4.09765625
ify 0.0030059814453125
▁distinct 9.2421875
▁kinds 6.21484375
▁of 0.0249481201171875
▁information 3.470703125
▁for 3.92578125
▁subsequent 4.140625
▁un 7.984375
comp 5.40234375
licated 0.0643310546875
▁services 11.7109375
. 0.6669921875
▁Thus 4.34375
, 0.0245513916015625
▁research 4.5234375
ers 0.5400390625
▁can 1.380859375
▁compare 3.93359375
▁the 0.96337890625
▁effects 3.048828125
▁of 0.11041259765625
▁medic 4.4453125
ations 0.91552734375
▁on 1.84375
▁patients 2.146484375
▁of 4.51953125
▁diverse 4.078125
▁age 2.7265625
▁groups 0.67041015625
, 0.92138671875
▁background 5.05859375
s 0.2156982421875
, 0.071533203125
▁physical 5.3984375
▁conditions 1.396484375
, 0.08929443359375
▁emot 5.5078125
ional 0.064697265625
▁states 1.3974609375
, 0.10687255859375
▁and 0.447265625
▁so 3.2109375
▁on 0.313720703125
. 0.091796875
<0x0A> 0.71875
The 1.1220703125
▁analysis 4.53125
▁of 0.5556640625
▁any 8.734375
▁human 6.0546875
▁reaction 4.78125
▁has 4.56640625
▁a 1.73046875
▁high 4.4921875
▁potential 3.3671875
▁of 1.6513671875
▁subject 6.28515625
iveness 3.85546875
▁and 1.318359375
▁bias 2.255859375
, 1.8720703125
▁especially 2.455078125
▁regarding 4.359375
▁people 4.49609375
▁in 3.955078125
▁severe 4.37109375
▁pain 0.30859375
▁and 2.650390625
▁un 5.36328125
stable 1.8271484375
▁emot 0.83740234375
ional 0.172607421875
▁condition 2.521484375
. 0.07366943359375
▁Perhaps 8.875
▁some 5.0703125
▁patients 2.43359375
▁tend 5.39453125
▁to 0.0215301513671875
▁ex 2.5703125
agger 0.0018463134765625
ate 0.00665283203125
▁their 0.744140625
▁de 5.1171875
press 1.4384765625
ive 0.271484375
▁state 3.095703125
▁or 1.869140625
▁vice 7.42578125
▁vers 0.01806640625
a 0.00015723705291748047
, 1.02734375
▁de 7.48828125
- 4.7734375
emph 0.9736328125
as 0.006427764892578125
ize 0.132080078125
▁serious 6.62890625
▁difficulties 5.9453125
. 0.88623046875
▁Because 6.19140625
▁the 2.314453125
▁survey 6.1640625
▁responses 6.64453125
▁were 1.6201171875
▁thoroughly 7.8984375
▁anonymous 5.2578125
, 0.45361328125
▁the 1.4443359375
▁research 1.529296875
ers 0.270751953125
▁were 1.435546875
▁unable 2.453125
▁to 0.004505157470703125
▁carefully 8.71875
▁analyze 1.5380859375
▁each 3.94921875
▁patient 2.5546875
’ 27.046875
s 0.8173828125
▁reaction 3.701171875
▁and 2.37109375
▁compare 3.486328125
▁it 0.86572265625
▁to 1.2490234375
▁the 0.771484375
▁actual 5.73828125
▁states 7.24609375
▁of 0.70458984375
▁condition 7.3125
. 0.381103515625
▁More 6.85546875
▁accurate 3.833984375
▁answers 4.6875
▁could 2.5078125
▁be 0.9130859375
▁obtained 1.0009765625
▁by 1.3662109375
▁professional 7.46484375
▁psych 2.193359375
olog 0.30517578125
ists 0.0017881393432617188
▁via 8.015625
▁personal 3.921875
▁communication 4.73828125
▁and 1.8134765625
▁behavior 7.171875
al 0.330078125
▁analysis 2.208984375
. 0.2232666015625
▁However 2.732421875
, 0.0028076171875
▁this 1.927734375
▁method 2.8671875
▁of 2.2890625
▁research 2.115234375
▁is 0.94287109375
▁way 7.80859375
▁more 1.693359375
▁resource 6.5703125
- 0.427734375
int 0.560546875
ensive 0.0088958740234375
▁and 0.61572265625
▁energy 8.6953125
- 0.11724853515625
consum 0.3037109375
ing 0.0019855499267578125
. 0.58837890625
<0x0A> 0.64599609375
Part 5.64453125
icip 0.09307861328125
ants 0.126220703125
▁were 1.0146484375
▁rec 1.5498046875
ru 0.0015239715576171875
ited 0.0001842975616455078
▁for 1.1171875
▁six 1.09375
▁months 0.0243377685546875
▁at 0.43701171875
▁two 0.1004638671875
▁major 0.364013671875
▁pain 0.03912353515625
▁relief 0.0287017822265625
▁cent 0.025787353515625
ers 0.00921630859375
▁in 0.06060791015625
▁Israel 0.032440185546875
. 0.139892578125
▁All 3.53125
▁patients 1.6123046875
▁experienced 5.453125
▁chron 1.8212890625
ic 0.0030059814453125
▁pain 0.09942626953125
▁for 3.427734375
▁at 0.73291015625
▁least 0.00170135498046875
▁ 1.05078125
3 1.44140625
▁months 0.2386474609375
. 0.99853515625
▁The 1.46484375
▁study 1.943359375
▁included 2.1953125
▁ 1.0986328125
8 2.896484375
9 2.77734375
0 3.45703125
▁participants 1.421875
, 1.2470703125
▁of 1.779296875
▁which 0.408447265625
▁ 0.1461181640625
4 1.642578125
7 2.46484375
4 2.76171875
▁( 2.240234375
5 0.1015625
9 11.0625
%) 1.017578125
▁were 0.467529296875
▁treated 4.640625
▁sole 6.8046875
ly 0.00021564960479736328
▁with 0.346435546875
▁op 0.85693359375
io 0.385986328125
ids 0.2034912109375
, 1.1435546875
▁ 0.60400390625
3 1.0849609375
2 2.111328125
9 2.578125
▁( 0.050628662109375
4 1.1796875
1 1.2216796875
%) 0.1295166015625
▁were 1.3388671875
▁treated 0.51806640625
▁with 0.1619873046875
▁MM 0.923828125
, 0.2607421875
▁and 0.1533203125
▁ 0.1451416015625
7 3.236328125
7 2.412109375
▁( 0.1817626953125
8 3.822265625
. 1.142578125
6 2.96484375
%) 0.059326171875
▁acquired 9.65625
▁both 1.103515625
▁( 6.92578125
Fe 10.1015625
ing 2.8359375
old 0.020782470703125
▁et 1.435546875
▁al 0.026947021484375
., 0.306396484375
▁ 0.01399993896484375
2 0.1478271484375
0 0.0006504058837890625
1 0.38330078125
7 2.060546875
). 0.1337890625
▁The 1.328125
▁remaining 7.015625
▁ten 8.0546875
▁participants 1.3486328125
▁who 5.625
▁did 1.4658203125
▁not 0.00771331787109375
▁receive 1.7919921875
▁ph 3.203125
arma 0.08221435546875
ce 0.002201080322265625
ut 0.0001169443130493164
ical 0.0038433074951171875
▁op 1.03125
io 0.1011962890625
ids 0.0258636474609375
▁and 1.6650390625
▁medical 1.8046875
▁mar 0.04681396484375
iju 0.0088958740234375
ana 0.00015461444854736328
▁were 1.2880859375
▁with 6.08203125
dra 0.1591796875
wn 0.00017547607421875
▁from 0.253662109375
▁the 0.10888671875
▁analysis 4.6328125
▁in 4.828125
▁the 1.201171875
▁research 4.296875
. 0.75048828125
▁Therefore 4.8515625
, 0.0077972412109375
▁it 3.748046875
▁is 0.869140625
▁not 2.6953125
▁possible 0.66015625
▁to 0.0198822021484375
▁compreh 6.50390625
ens 0.048614501953125
ively 0.01104736328125
▁compare 1.8984375
▁patients 4.8203125
▁taking 4.328125
▁medic 3.931640625
ations 0.446533203125
▁with 0.98828125
▁those 1.2236328125
▁who 1.123046875
▁do 1.7138671875
▁not 0.008697509765625
. 0.791015625
<0x0A> 0.64892578125
The 1.1259765625
▁study 1.7099609375
▁conducted 4.7421875
▁a 2.09765625
▁correlation 5.91796875
▁type 7.4453125
▁of 0.4404296875
▁research 1.978515625
▁with 2.857421875
▁variable 7.94921875
▁measures 4.56640625
. 1.267578125
▁It 2.103515625
▁evaluated 4.38671875
▁the 0.56689453125
▁inter 6.2578125
dep 3.623046875
end 0.0008120536804199219
ence 0.01160430908203125
▁of 0.568359375
▁various 3.9140625
▁factors 1.6240234375
▁that 2.822265625
▁affected 4.1328125
▁the 0.576171875
▁physical 6.9296875
▁and 0.94384765625
▁emot 0.50439453125
ional 0.0004334449768066406
▁condition 1.041015625
▁of 0.111572265625
▁patients 0.63134765625
▁experien 4.09765625
cing 4.661083221435547e-05
▁chron 0.525390625
ic 0.0005731582641601562
▁pain 0.027801513671875
. 0.217529296875
▁For 3.85546875
▁example 1.107421875
, 0.01495361328125
▁the 1.2021484375
▁survey 5.12109375
▁showed 3.36328125
▁that 0.405029296875
▁the 1.7314453125
▁ratio 6.9921875
▁of 0.12347412109375
▁female 4.46875
▁patients 0.78955078125
▁was 1.880859375
▁remark 9.53125
ably 0.0007991790771484375
▁higher 0.5205078125
▁in 2.7109375
▁the 0.98486328125
▁op 4.48046875
i 4.0
ates 0.1168212890625
▁group 0.278564453125
▁compared 2.7421875
▁to 0.11468505859375
▁the 0.53125
▁MM 0.5185546875
▁group 0.2724609375
. 0.46923828125
▁In 2.998046875
▁turn 3.984375
, 0.002971649169921875
▁people 5.96875
▁on 5.46875
▁op 1.4794921875
i 0.4765625
ates 0.004245758056640625
▁were 1.048828125
▁more 0.98828125
▁likely 0.381591796875
▁to 0.059967041015625
▁report 3.1015625
▁major 5.97265625
▁de 0.38671875
press 1.2177734375
ive 0.00421905517578125
▁dis 0.5048828125
orders 1.3720703125
. 1.759765625
<0x0A> 2.484375
The 1.123046875
▁question 5.68359375
na 1.33203125
ires 0.00011730194091796875
▁used 2.029296875
▁different 8.15625
▁variable 8.6953125
▁measures 0.76708984375
▁to 1.361328125
▁collect 2.353515625
▁information 1.931640625
. 1.6123046875
▁For 1.9892578125
▁example 0.2071533203125
, 0.007617950439453125
▁it 4.0390625
▁included 2.46875
▁compreh 8.7109375
ensive 0.02740478515625
▁so 6.890625
cio 0.025665283203125
- 0.427734375
dem 0.08642578125
ographic 0.040802001953125
▁data 1.00390625
: 4.8359375
▁gender 1.568359375
, 0.08941650390625
▁age 0.19873046875
, 0.090576171875
▁country 4.3671875
, 1.47265625
▁type 4.3515625
▁of 0.0576171875
▁residence 3.79296875
▁( 3.48828125
urban 2.048828125
/ 2.919921875
r 0.06292724609375
ural 0.0008120536804199219
), 0.240478515625
▁years 5.94140625
▁of 0.1632080078125
▁education 0.67578125
, 0.1434326171875
▁and 1.8447265625
▁employ 3.681640625
ment 0.004230499267578125
▁status 0.4541015625
. 0.1741943359375
▁Pat 4.0859375
ients 0.096923828125
▁were 1.1748046875
▁also 0.87841796875
▁asked 0.60693359375
▁about 1.1435546875
▁their 0.61474609375
▁medical 2.6875
▁history 0.392822265625
▁over 8.78125
▁the 0.161376953125
▁years 4.0
▁and 1.8154296875
▁the 1.826171875
▁current 3.376953125
▁presence 5.8359375
▁of 0.05322265625
▁any 2.6796875
▁severe 4.609375
▁dise 1.484375
ases 9.334087371826172e-05
▁such 4.2109375
▁as 0.004695892333984375
▁heart 2.41015625
▁failure 2.0546875
, 0.18359375
▁di 1.8603515625
ab 0.001964569091796875
etes 0.00445556640625
, 0.123291015625
▁ar 3.796875
th 0.12890625
rit 0.03460693359375
is 0.01219940185546875
, 0.04156494140625
▁and 1.568359375
▁so 0.73779296875
▁on 0.031280517578125
. 0.0509033203125
▁The 1.8671875
▁third 7.2421875
▁measure 3.927734375
▁of 2.0625
▁the 0.9736328125
▁question 2.818359375
naire 0.1705322265625
▁was 0.970703125
▁indicated 9.71875
▁by 0.62158203125
▁information 6.55859375
▁on 1.5888671875
▁any 5.3125
▁twelve 13.6484375
- 1.1513671875
month 0.3603515625
▁and 5.77734375
▁lifetime 3.205078125
▁drug 4.71875
▁and 3.462890625
▁alco 0.0784912109375
hol 0.00010669231414794922
▁consumption 2.5703125
. 0.456787109375
▁In 3.5078125
▁addition 0.80908203125
, 0.125
▁the 1.1474609375
▁record 7.84765625
▁included 1.7421875
▁a 2.501953125
▁pain 6.34375
▁measurement 4.28125
▁scale 1.029296875
▁from 3.634765625
▁ 0.440185546875
0 0.430419921875
▁to 0.4287109375
▁ 0.007419586181640625
1 0.08416748046875
0 0.0706787109375
▁to 4.60546875
▁evaluate 1.5478515625
▁dis 5.9609375
com 0.2052001953125
fort 0.0016489028930664062
▁feelings 7.375
▁during 3.326171875
▁the 0.912109375
▁last 1.4404296875
▁month 1.58203125
. 0.282958984375
<0x0A> 1.123046875
Am 6.953125
ong 0.01311492919921875
▁all 2.357421875
▁participants 1.974609375
▁in 3.5546875
▁the 0.1800537109375
▁study 0.383544921875
, 0.054779052734375
▁ 0.6669921875
4 1.7724609375
2 2.73828125
. 1.7763671875
2 2.298828125
% 0.1474609375
▁suffered 4.80859375
▁from 0.1376953125
▁de 1.802734375
pression 0.1654052734375
, 1.080078125
▁and 1.78125
▁ 0.1505126953125
3 1.7119140625
7 2.23828125
% 2.728515625
▁experienced 2.287109375
▁excess 7.796875
ive 0.0865478515625
▁anx 0.26220703125
iety 0.001743316650390625
. 0.345458984375
▁The 1.4052734375
▁pl 11.1640625
ur 0.99560546875
ality 0.00021541118621826172
▁of 0.1905517578125
▁de 3.568359375
press 1.2724609375
ive 0.0243988037109375
▁dis 1.7998046875
orders 0.05828857421875
▁among 3.796875
▁patients 1.2080078125
▁in 3.6015625
▁the 0.369140625
▁op 1.4140625
i 0.9892578125
ates 0.00559234619140625
, 7.0703125
▁medical 2.64453125
▁mar 0.0211639404296875
iju 0.009368896484375
ana 5.7578086853027344e-05
, 0.11102294921875
▁and 0.06414794921875
▁mixed 5.8359375
▁OP 8.3515625
MM 6.37890625
▁groups 0.485595703125
▁number 8.03125
ed 0.00982666015625
▁ 0.12139892578125
5 2.1953125
7 2.486328125
. 0.2021484375
1 2.369140625
%, 0.24365234375
▁ 0.004489898681640625
2 3.0078125
2 2.43359375
. 0.102294921875
3 2.232421875
%, 0.11566162109375
▁and 0.032867431640625
▁ 0.0031337738037109375
5 3.220703125
1 2.548828125
. 0.164794921875
4 2.14453125
%, 0.388427734375
▁respectively 0.0098876953125
. 0.2919921875
▁The 1.4560546875
▁pl 4.53125
ur 0.0213165283203125
ality 3.5762786865234375e-05
▁of 0.039886474609375
▁anx 0.8955078125
iety 0.0112457275390625
▁contained 11.046875
▁ 0.54150390625
4 1.5830078125
8 2.380859375
. 0.062744140625
4 2.306640625
% 0.499267578125
▁among 1.45703125
▁OP 6.4453125
▁patients 8.9765625
, 0.2763671875
▁ 0.09637451171875
2 1.4931640625
1 2.416015625
. 0.129638671875
5 2.42578125
% 0.01142120361328125
▁among 0.41162109375
▁MM 0.38232421875
▁patients 0.2437744140625
, 0.01163482666015625
▁and 0.01297760009765625
▁ 0.037017822265625
3 1.23046875
8 2.640625
. 0.156005859375
7 2.29296875
% 0.013427734375
▁among 0.2315673828125
▁OP 4.2421875
MM 0.267822265625
▁participants 3.6015625
. 0.2236328125
▁Pat 5.78125
ients 0.022491455078125
▁who 2.3828125
▁took 2.9375
▁strong 7.9921875
▁op 1.3056640625
i 1.4375
ates 0.0036754608154296875
▁were 1.7548828125
▁t 8.8203125
ended 1.5205078125
▁to 0.0137939453125
▁place 10.40625
▁their 3.6953125
▁pain 2.62890625
▁on 3.44140625
▁a 0.8701171875
▁scale 2.279296875
▁of 0.630859375
▁ 0.33740234375
9 2.833984375
▁to 1.3662109375
▁ 0.016357421875
1 0.023162841796875
0 0.09161376953125
▁( 2.55078125
Fe 1.6767578125
ing 0.00850677490234375
old 0.0005216598510742188
▁et 0.029327392578125
▁al 0.0017032623291015625
., 0.0071258544921875
▁ 0.0019817352294921875
2 0.0005421638488769531
0 5.364418029785156e-05
1 0.0020198822021484375
7 0.01319122314453125
). 0.049346923828125
▁They 4.71875
▁were 1.28515625
▁also 1.396484375
▁an 8.8515625
gu 4.53125
ished 0.03411865234375
▁em 8.5390625
otion 0.012603759765625
ally 0.0032825469970703125
▁and 1.1220703125
▁react 6.87109375
ed 0.056060791015625
▁rad 9.5
ically 0.004543304443359375
▁neg 5.41015625
atively 0.001102447509765625
▁to 0.34765625
▁almost 5.2421875
▁all 1.1953125
▁survey 8.4609375
▁questions 0.6259765625
. 0.2919921875
▁Pat 4.25
ients 0.007709503173828125
▁who 1.15625
▁took 1.505859375
▁only 5.42578125
▁MM 0.9775390625
▁or 3.2734375
▁mixed 3.3359375
▁medic 2.58984375
ations 0.3291015625
▁course 12.7578125
▁had 2.466796875
▁a 1.2783203125
▁significantly 2.544921875
▁more 4.08203125
▁stable 3.40625
▁emot 1.1943359375
ional 0.007480621337890625
▁state 0.81982421875
▁and 1.4052734375
▁cop 5.5078125
ed 0.8447265625
▁with 0.7138671875
▁pain 1.4453125
▁more 1.681640625
▁manage 6.9609375
able 2.3671875
. 0.52587890625
<0x0A> 0.70068359375
One 5.1484375
▁of 0.6025390625
▁the 0.0173492431640625
▁major 2.544921875
▁limitations 2.763671875
▁is 3.912109375
▁the 0.51123046875
▁ins 4.78125
u 0.0182952880859375
fficient 0.1217041015625
ly 4.70703125
▁high 2.962890625
▁response 2.990234375
▁rate 0.11651611328125
, 2.673828125
▁ 4.6171875
5 1.9150390625
7 2.0390625
% 2.134765625
▁instead 7.26953125
▁of 0.00579071044921875
▁ 0.69677734375
7 1.5185546875
0 1.458984375
% 1.119140625
▁( 1.6025390625
Fe 0.259033203125
ing 0.004192352294921875
old 0.0005946159362792969
▁et 0.006519317626953125
▁al 0.001262664794921875
., 0.004863739013671875
▁ 0.0015630722045898438
2 0.00041294097900390625
0 3.0517578125e-05
1 0.0009617805480957031
7 0.006572723388671875
). 0.035888671875
▁It 2.671875
▁can 3.28125
▁be 0.412353515625
▁fairly 8.34375
▁explained 1.4482421875
▁by 0.1693115234375
▁the 0.33056640625
▁weak 8.2265625
▁focus 7.125
▁of 0.470703125
▁respond 6.28515625
ents 0.131103515625
▁who 3.533203125
▁have 4.0625
▁overcome 8.1171875
▁severe 2.2890625
▁pain 0.491455078125
▁sens 8.703125
ations 1.1123046875
▁and 1.189453125
▁de 4.1953125
press 1.74609375
ive 0.251708984375
▁episodes 3.98828125
. 0.6005859375
▁It 3.3515625
▁is 0.8291015625
▁not 2.650390625
▁clear 4.23828125
▁how 1.6787109375
▁to 3.578125
▁use 5.39453125
▁these 3.046875
▁statistics 3.3984375
, 2.546875
▁as 1.392578125
▁they 1.36328125
▁still 6.12890625
▁may 4.80078125
▁be 1.3291015625
▁relevant 5.296875
▁for 1.3896484375
▁the 1.837890625
▁overall 4.48046875
▁analysis 3.078125
. 1.0693359375
